Zealand Pharma A/S | ZEAL - Cost Of Sales

Stock Price
301.50
Daily Change
2.00 0.67%
Monthly
-4.68%
Yearly
-28.55%
Q2 Forecast
295.91

Zealand Pharma A/S reported 410K in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zealand Pharma A/S 410K 5K Jun/2025